| 1. | Details of PDMR/person closely associated with them ('PCA') | ||
| a) | Name | Mr Roger Connor | |
| b) | Position/status | President, Global Manufacturing & Supply | |
| c) | Initial notification/ amendment | Initial Notification | |
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | GlaxoSmithKline plc | |
| b) | LEI | 5493000HZTVUYLO1D793 | |
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 | |
| b) | Nature of the transaction | Transfer of 49,152 Ordinary Shares between accounts. No change in beneficial ownership. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.00 | 49,152 | ||
| d) | Aggregated information | n/a (single transaction) | |
| Aggregated volume Price | |||
| e) | Date of the transaction | 2018-04-26 | |
| f) | Place of the transaction | n/a | |
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||
| a) | Name | Mr Roger Connor | |
| b) | Position/status | President, Global Manufacturing & Supply | |
| c) | Initial notification/ amendment | Initial Notification | |
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | GlaxoSmithKline plc | |
| b) | LEI | 5493000HZTVUYLO1D793 | |
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 | |
| b) | Nature of the transaction | Transfer of 49,152 Ordinary Shares to spouse for nil consideration. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.00 | 49,152 | ||
| d) | Aggregated information | n/a (single transaction) | |
| Aggregated volume Price | |||
| e) | Date of the transaction | 2018-04-27 | |
| f) | Place of the transaction | n/a | |
| Details of PDMR/person closely associated with them ('PCA') | |||
| a) | Name | Mrs Denise Connor | |
| b) | Position/status | PCA of Mr Roger Connor (President, Global Manufacturing & Supply) | |
| c) | Initial notification/ amendment | Initial Notification | |
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | GlaxoSmithKline plc | |
| b) | LEI | 5493000HZTVUYLO1D793 | |
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 | |
| b) | Nature of the transaction | Receipt of 49,152 Ordinary Shares from spouse for nil consideration. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.00 | 49,152 | ||
| d) | Aggregated information | n/a (single transaction) | |
| Aggregated volume Price | |||
| e) | Date of the transaction | 2018-04-27 | |
| f) | Place of the transaction | n/a | |
| GlaxoSmithKline plc | |
| (Registrant) | |
| Date: April 27, 2018 | |
By: VICTORIA WHYTE -------------------------- | |
| Victoria Whyte | |
| Authorised Signatory for and on | |
| behalf of GlaxoSmithKline plc |
